CRACK MEDICINE

TL;DR; In MRCP Part 1 , oncological emergencies are tested through pattern recognition and first-step management . Superior vena cava (SVC) syndrome and sepsis can look similar in cancer patients, but they differ fundamentally in physiology and immediate action. This article contrasts both conditions using exam-focused points, a mini-case, common traps, and a practical revision checklist. Why this topic matters in MRCP Part 1 Oncological emergencies are high-yield because the

TL;DR; Paraneoplastic syndromes are a high-yield, pattern-recognition topic in MRCP Part 1 , frequently tested via endocrine, neurological, dermatological, and metabolic clues rather than overt cancer features. If you can rapidly link syndrome → mechanism → tumour , you can secure straightforward marks. This article summarises the most tested associations, common traps, and a focused study checklist. Why paraneoplastic syndromes matter for MRCP Part 1 Paraneoplastic syndromes

TL;DR Tumour markers are a high-yield, frequently tested topic in MRCP Part 1 , but questions focus on appropriate use  rather than raw memorisation. You are expected to know classic marker–tumour associations, common benign causes of elevation, and when markers are useful for diagnosis, monitoring, or prognosis. This article gives an exam-ready list, common traps, a mini-MCQ, and a practical revision checklist. Why tumour markers matter in MRCP Part 1 Tumour markers appear d

TL;DR; Psychiatry questions in MRCP Part 1  frequently test your ability to distinguish between similar conditions  rather than recall definitions. This clinician-written rapid review covers the most examined contrasts, classic traps, and drug effects. Use it as a consolidation piece alongside question practice and core notes. Why psychiatry “difference questions” matter In the MRCP Part 1 written paper, psychiatry questions are often subtle. Candidates lose marks by confusin

TL;DR:   This clinician-written guide summarises the most exam-relevant oncology differences  tested in MRCP Part 1 —tumour markers, paraneoplastic syndromes, classic presentations, and management principles. It includes a worked MCQ-style case, common traps, and a practical revision checklist. Use it to sharpen pattern recognition rather than memorise low-yield detail. Why oncology differences matter in MRCP Part 1 Oncology in MRCP Part 1  is not about comprehensive cancer m

TL;DR:  Anxiety disorders, PTSD, and OCD are consistently tested in MRCP Part 1 , mainly through diagnosis, timelines, and first-line management. Focus on distinguishing anxiety subtypes, recognising PTSD duration criteria, and knowing evidence-based treatments (CBT and SSRIs). Most marks are gained by avoiding common diagnostic and pharmacological traps. Why this topic matters in MRCP Part 1 Psychiatry contributes a reliable number of single best answer questions in MRCP Par

TL;DR:   For MRCP Part 1 , the most reliable way to distinguish Neuroleptic Malignant Syndrome (NMS)  from Serotonin Syndrome  is to focus on drug exposure, onset, and neuromuscular findings . Lead-pipe rigidity with gradual onset  points to NMS, while clonus and hyperreflexia with rapid onset  indicate serotonin syndrome. Correct identification determines the correct antidote and is a high-yield exam discriminator. Why this topic is high-yield for MRCP Part 1 NMS and seroton

TL;DR Mood disorders are a high-yield psychiatry topic in MRCP Part 1 , most commonly testing diagnostic criteria, differentiation between unipolar depression and bipolar disorder, and first-line pharmacology. Examiners favour subtle distinctions such as mania versus hypomania, antidepressant-induced switching, and lithium safety. This article provides an exam-focused framework, a worked MCQ, common traps, and a practical revision checklist. Why mood disorders matter in MRCP

TL;DR: Schizophrenia and related psychotic disorders are a reliable scoring area in MRCP Part 1  if you know definitions, timelines, symptom clusters, and antipsychotic adverse effects. Questions are usually clinical vignettes testing differentiation from mood disorders, delirium, and substance-induced psychosis. This article gives a focused, exam-ready framework with a mini-MCQ and a practical revision checklist. Why schizophrenia & psychosis matter in MRCP Part 1 Psychiatry

TL;DR; Odds ratio (OR) and relative risk (RR) are measures of association commonly tested in MRCP Part 1 . RR is intuitive and used in cohort studies and randomised controlled trials, while OR is standard in case–control studies and logistic regression. OR approximates RR only when the outcome is rare; misinterpreting this is a frequent exam trap. Why this topic matters for MRCP Part 1 Medical statistics questions in MRCP Part 1 are designed to test interpretation , not advan

TL;DR:   Psychiatry is a small but reliable scoring area in MRCP Part 1 . Questions focus on core diagnoses, drug adverse effects, delirium–dementia differentiation, and capacity. This article outlines the examinable scope, high-yield facts, common traps, one MCQ-style case, and a practical revision checklist. Why psychiatry matters in MRCP Part 1 Psychiatry typically contributes a modest proportion of the written paper, but the yield is disproportionately high. Questions are

TL;DR:   MRCP Part 1  regularly tests whether you can recognise bias and confounding, distinguish them from effect modification, and choose the correct control method. You are not expected to calculate statistics, but you must interpret study descriptions accurately. This article covers exam-favourite biases, confounding logic, common traps, and a short MCQ to consolidate marks. Why bias and confounding matter in MRCP Part 1 Epidemiology and research methods are dependable sc

TL;DR: NNT (Number Needed to Treat) and NNH (Number Needed to Harm) are high-yield statistics repeatedly tested in MRCP Part 1 . They are simple to calculate once you focus on absolute  risk, not relative risk. This article explains the concepts clearly, shows you how to calculate them step by step, highlights common exam traps, and includes an exam-style MCQ. Why NNT and NNH matter in MRCP Part 1 In MRCP Part 1, statistics are not tested in isolation. NNT and NNH are usually

TL;DR; For MRCP Part 1 , you must rapidly identify study designs from short vignettes and choose the correct measure of association. Case-control studies suit rare diseases and report odds ratios; cohort studies suit rare exposures and report risk; randomised controlled trials (RCTs) test treatment efficacy with the strongest causal inference. This article distils examiner favourites, common traps, and a worked MCQ to help you score reliably. Why study design questions matter

TL;DR This clinician-written guide summarises the drug of choice  decisions most frequently tested in dermatology for MRCP Part 1 . It focuses on first-line therapy, escalation rules, and common traps, with a short MCQ and a practical revision checklist. Use this alongside structured revision from the MRCP Part 1  hub and question practice to lock in marks. Why dermatology drug choice matters in MRCP Part 1 Dermatology contributes a small but highly predictable  share of Part

TL;DR:   Likelihood ratios translate test results into meaningful changes in disease probability and are repeatedly examined in MRCP Part 1 . They outperform sensitivity and specificity for bedside decision-making and allow rapid rule-in or rule-out without complex maths. Mastering a few thresholds and traps can secure easy marks across multiple systems. Why likelihood ratios matter in MRCP Part 1 MRCP examiners favour tools that assess clinical reasoning . Likelihood ratios

TL;DR Predictive values tell you how useful a test result is in real patients , and they change with disease prevalence. In MRCP Part 1 , most candidates lose marks by forgetting that PPV rises with higher prevalence, while NPV rises with lower prevalence. If you can identify the population and reason directionally, these questions become straightforward. Why this topic matters in MRCP Part 1 Predictive values sit at the intersection of epidemiology, screening, and clinical r

TL;DR: Sensitivity, specificity, predictive values, and statistical power are repeatedly tested in MRCP Part 1 , usually through interpretation rather than calculation. This article explains what each term means in practice, how examiners frame questions, and how to avoid common traps. A short MCQ-style case and a practical revision checklist are included to support efficient exam preparation. Why this topic matters for MRCP Part 1 Statistics is one of the most consistently e

TL;DR This article explains how biochemistry is tested in MRCP Part 1 , highlights the most exam-relevant areas, and shows how to practise MCQs efficiently. It includes high-yield revision points, a worked example MCQ, common traps, and a practical checklist to improve scores with focused study. Why biochemistry matters in MRCP Part 1 Clinical biochemistry forms a substantial part of the Clinical Sciences  syllabus in MRCP Part 1. Questions are rarely about memorising entire

TL;DR:   Molecular biology in MRCP Part 1  focuses on mechanisms, not laboratory trivia. Master the central dogma, mutation types, DNA repair, gene regulation, and core molecular techniques to secure predictable marks. This article outlines high-yield content, common traps, a mini-MCQ, and a practical revision checklist. Why molecular biology matters in MRCP Part 1 Molecular biology underpins genetics, oncology, pharmacology, and many metabolic disorders tested in MRCP Part 1